Frankly Speaking About Family Medicine

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268 Overview: This episode will help bring awareness to the importance of educating patients about post-exposure prophylaxis (PrEP) in the primary care setting. This talk will also discuss how to reduce the stigma surrounding this prevention method. Finally, you will hear about the newly FDA approved PrEP treatment option that could potentially improve outcomes for patients.    Episode resource links: https://www.healio.com/news/infectious-disease/20211220/fda-approves-first-longacting-injectable-for-hiv-prevention Philbin, M. M., Parish, C., Kinnard, E. N., Reed, S. E., Kerrigan, D., Alcaide, M. L., ... & Metsch, L. R. (2021). Interest in long-acting injectable pre-exposure prophylaxis (LAI PrEP) among women in the women’s interagency HIV study (WIHS): a qualitative study across six cities in the United States. AIDS and Behavior, 25(3), 667-678.   Kim Y.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-267 Overview: The clinical literature is filled with new and evolving evidence on the use of e-cigarettes and potential harms. The question of their use as a harm reduction strategy is a hotly debated topic—pitting traditional combustible tobacco with its well-known effect on morbidity and mortality against electronic nicotine delivery systems (ENDS), which although not harmless, are considered less harmful than smoked cigarettes. Recent evidence is emerging on the potential cardiovascular risks posed by newer generations of ENDS with far greater delivery of nicotine. Join us while we discuss the findings from a recent study that examines ENDS use and associated increase rates of erectile dysfunction (ED) and how this information may impact your practice. Episode resource links: El-Shahawy O, Shah T, Obisesan OH, Durr M, Stokes AC, Uddin I, Pinjani R, Benjamin

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-266 Overview: ‘Tis the season for pediatric fevers! Join us to review a recent meta-analysis looking at 18 studies with patients younger than 2 years old who received acetaminophen or ibuprofen for fever or pain to determine if one medication should be recommended first, before the other. After this session, you’ll be able to confidently advise parents of young children on how best to manage fever and/or pain at home with over-the-counter medications.   Episode resource links: Long B, Gottlieb M. Ibuprofen vs. Acetaminophen for Fever or Pain in Children Younger Than Two Years. Am Fam Physician. 2022 Jan ;105(1):19. Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Evid Based Child Health. 2014 Sep;9(3):675-729. doi: 10.1002/ebch.1978. PMID: 25236309. S

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-241   Overview: Seven percent of the US population has an active levothyroxine prescription, which is significantly greater than the number of people diagnosed with overt hypothyroidism. Many of these prescriptions appear to be for the treatment of subclinical hypothyroidism and other conditions in euthyroid individuals. Join us to uncover the latest findings on the use of levothyroxine and what the evidence tells us about appropriate use and misuse of this drug.   Episode resource links: Brito, J., Ross, J., El Kawkgi, O., Maraka, S., Deng, Y., Shah, N., Lipska, K. & (9000). Levothyroxine Use in the United States, 2008-2018. JAMA Internal Medicine, Publish Ahead of Print, doi: 10.1001/jamainternmed.2021.2686. Johansen, M., Marcinek, J., Yun, J. & (2020). Thyroid Hormone Use in the United States, 1997–2016. Journal of the American Board of Family Medicin

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-265 Overview: Most cases of COVID-19 will resolve without interventions, but some patients are at high risk for complications. Several treatment options for high-risk patients are now available to help prevent the need for hospitalization. Join us to review a recent large, randomized trial evaluating fluvoxamine as a treatment for high-risk patients who were diagnosed with COVID-19.   Episode resource links: Reis G, et al. TOGETHER investigators. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022 Jan;10(1):e42-e51 Berwanger O. Fluvoxamine for outpatients with COVID-19: where do we stand? Lancet Glob Health. 2022 Jan;10(1):e2-e3. doi: 10.1016/S2214-109X(21)00501-5 https://activ6study.org/ Guest: Alan M. Ehrlich, MD, FAAFP

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-264 Overview: Get answers to your questions on COVID-19 infection in children. Listen to this podcast to review outcomes and potential risk factors associated with acute COVID-19 infection in this population. Finally, learn the status of immunizations for children younger than 5 years of age.   Episode resource links: JAMA Netw Open. 2022;5(1):e2142322. doi:10.1001/jamanetworkopen.2021.42322 Guest: Jillian Joseph, MSPAS, PA-C   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263   Overview: The FDA’s recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer’s Paxlovid and Merck’s molnupiravir antiviral agents and give you the information you need to confidently prescribe them.   Episode resource links: FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov) FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov) Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-262   Overview: Join us as we discuss menopausal transition and the unique qualities and symptoms that are bothersome to women at an early age.   Episode resource links: Coslov, N., Richardson, M. K., & Woods, N. F. (2021). Symptom experience during the late reproductive stage and the menopausal transition: observations from the Women Living Better survey. Menopause (New York, N.Y.), 28(9), 1012–1025. https://doi.org/10.1097/GME.0000000000001805 https://pubmed.ncbi.nlm.nih.gov/34313615/   ACOG Practice Guidelines: Clinical Guidelines on the Management of Menopausal Symptoms: https://www.aafp.org/afp/2014/0901/p338.html Women Living Better Website:  https://womenlivingbetter.org/ Maki, P. M., Kornstein, S. G., Joffe, H., Bromberger, J. T., Freeman, E. W., Athappilly, G., Bobo, W. V., Rubin, L. H., Koleva, H. K., Cohen, L. S., Soares,

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-261   Overview: Stroke is a major health problem, and the risk of stroke is five-times higher in individuals with atrial fibrillation (AF) than those without. AF can be asymptomatic or subclinical. In 18% of AF patients, the condition is only detected at the time of stroke. It is not known whether individuals whose AF is deterred via screening carry a similar risk to individuals with known AF. A recent randomized trial evaluated a screening program for AF in individuals at high risk of stroke; for individuals identified with AF, anticoagulation was given for stroke prevention.   Episode resource links: Svendsen JH, Diederichsen SZ, Højberg S et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021 Oct 23;398(10310):1507-1516 Guest: Alan Ehrlich MD, FAAFP  

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-260   Overview: We will review the current USPSTF recommendations regarding aspirin use to reduce the risk of CVD and colorectal cancer. Additionally, we will discuss as well as the findings of the ASPREE (ASPirin in reducing events in the elderly) randomized clinical trial.   Episode resource links: POEMs: In Older Adults, Aspirin Increases the Risk of Metastatic of Stage 4 Cancers and Cancer Mortality. Barry, Henry C. Am Fam Physician. 2021 Sep; 104(2):online Effect of Aspirin on Cancer Incidence and Mortality in Older Adults. McNeil, John. JNCI: Journal of the National Cancer Institute Volume: 113 Issue 3 (2021) ISSN: 0027-8874 Online ISSN: 1460-2105 Guest: Jillian Joseph, MSPAS, PA-C   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-259   Overview: Per CDC data, approximately 2.5 million Americans present each year to emergency departments with head injuries, and 15% of all high school students report experiencing at least one concussion. Current guidelines recommend physical and cognitive rest for 24-48 hours post-concussion with minimal guidance on screen time parameters. Recent evidence is emerging that supports avoidance of screen time and encouragement of aerobic activity as strategies to shorten and lessen post-concussion symptoms. Join us as we discuss 2 recent studies regarding screen-time and aerobic exercise that add critical information to best practice for reducing post-concussion symptoms.   Episode resource links: John J Leddy, Christina L Master, Rebekah Mannix, Douglas J Wiebe, Matthew F Grady, William P Meehan, Eileen P Storey, Brian T Vernau, Naomi J Brown,

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-258   Overview: Chronic pain affects 20% of people in the United States, and chronic low back pain is the most common cause of chronic pain. Although some treatments can reduce the severity of the pain, the persistence of chronic low back pain is a source of frustration for both patients and clinicians. Join us to discuss how behavioral and psychological therapy should be part of the treatment for chronic low back pain and how new approaches may be much more effective than existing therapies.   Episode resource links: Ashar YK, Gordon A, Schubiner H, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. Published online September 29, 2021. Guest: Alan Ehrlich MD, FAAFP   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-257   Overview: Gout is a common condition seen in primary care, and the incidence and prevalence continue to rise. Despite previous recommendations from the American College of Rheumatology, urate-lowering therapy is still underused. Listen to this episode for a concise overview of the American College of Rheumatology’s updates for the management of gout and walk away with a clear understanding of the first-line treatment options for acute gout flares.   Episode resource links: Management of Gout: Update from the American College of Rheumatology. Dakkak, M., Lanney, H. Am Fam Physician. 2021 Aug ;104(2):209-210. 2020 American College of Rheumatology Guideline for the Management of Gout. Fitzgerald, J. D. et al. Arthritis Care Res (Hoboken). June 2020;72(6):744–760 [published corrections appear in Arthritis Care Res (Hoboken). 2020;72(8):1187, and

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-256   Overview: Live at Pri-Med East! In this episode, each podcaster will discuss the most impactful paper and podcast of the year.   Episode resource links: Ngan, H.Y, et al (2021), Diabet Med, 38: e14525. https://doi.org/10.1111/dme.14525 J Clin Gastroenterol 2021: DOI: 10.1097/MCG.0000000000001561 Mehta RS, etal. JAMA Intern Med. doi:10.1001/jamainternmed.2020.7238 https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667   Guest: Susan Feeney, DNP, FNP-BC, NP-C, Alan M. Ehrlich, MD, FAAFP, Jill M. Terrien, PhD, ANP-BC, Jillian Joseph, MSPAS, PA-C   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-255   Overview: Asthma is one of the most prevalent conditions, affecting almost 340 million individuals across the globe and approximately 25 million Americans, or 7.8% of the US population. Treatment is complex and goals of therapy are elusive for many. Anxiety and other concerns are common in those diagnosed with asthma and can worsen outcomes. A recent study from the UK found the use of a mindfulness app was associated with improved asthma-related quality-of-life indicators. Join us while we discuss this study’s implications for helping patients with asthma in primary care.   Episode resource links: Ainsworth, B., Stanescu, S., Stuart, B., Russell, D., Liddiard, M., Djukanovic, R., & Thomas, M. (2021). A feasibility trial of a digital mindfulness-based intervention to improve asthma-related quality of life for primary care patients with as

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-254   Overview: Older adults who suffer from loneliness may be at risk of overusing medications prescribed for pain, insomnia, depression, or anxiety. Replacing these medications with social interventions may improve outcomes and help patients avoid adverse consequences. Join us as we discuss the importance of reviewing medications and assessing for loneliness in older adults to prevent adverse events and outcomes.   Episode resource links: Kotwal, A. A., Steinman, M. A., Cenzer, I., & Smith, A. K. (2021). Use of High-risk Medications Among Lonely Older Adults: Results From a Nationally Representative Sample. JAMA internal medicine, e213775. Advance online publication. https://doi.org/10.1001/jamainternmed.2021.3775 https://pubmed.ncbi.nlm.nih.gov/34309620/ Education for Patients: Tips on Staying Connected—National Institutes on Aging https://

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-253   Overview: ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are both recommended as first-line treatments for hypertension. ACE inhibitors have known side effects, such as cough, that are frustrating for many patients, while ARBs appear to have less annoying side effects. This podcast will review a recently published retrospective, comparative cohort study comparing the effectiveness and safety of ACE inhibitors vs ARBs in the first-line treatment of hypertension.   Episode resource links: Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667   ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Cli

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-252   Overview: For patients who would like to prevent pregnancy, many options—both hormonal and nonhormonal—exist. Despite the availability of multiple options, many patients do not use them because of either a lack of knowledge or a lack of access, the latter being especially true in uninsured and non−English-speaking communities. Research has shown over the years that while unintended pregnancies have decreased in the United States, more can be done, and primary care providers can play an important role in helping to further decrease and eliminate barriers to contraception.   Episode resource links: Lesnewski, R. (2021). Initiating Hormonal Contraception. American Family Physician, 103(5), 291-300. Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-251   Overview: Primary care providers should be up to date on the changes to the guidelines for cervical cancer screening to be able to guide patients in shared decision-making about health maintenance. Join us to review the recent changes to cervical cancer screening guidelines as recommended by the American Cancer Society.   Episode resource links: Cervical Cancer Screening: Updated Guidelines from the American Cancer Society. Am Fam Physician. 2021 Sep; 104(2):314-315. American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. Practice advisory. April 2021. Accessed September 30, 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines Fontham, ETH, Wolf, AMD, Church, TR, et al. Cervical Cancer Screening for Individuals at Aver

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-250   Overview: While the data conflict on how much sodium intake is optimal for preventing cardiovascular disease, it is clear that daily salt intake for most Americans exceeds what is recommended. However, restricting salt intake on an individual or on a public health level has been controversial. An interesting alternative is the use of salt substitutes, which can help to decrease sodium intake while increasing potassium intake, and both have been associated with lowering blood pressure. Join us to hear a discussion on the results of the recently published studies on salt and cardiovascular disease, along with an overview of the Salt Substitute and Stroke Study (SSaSS).   Episode resource links: Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. DOI: 10.1056/NEJMoa2105675 O’Donnell M, Ment